Janssen Immunology Supports World Autoimmune Arthritis Day Through Donate A Photo
Janssen Immunology Supports World Autoimmune Arthritis Day Through Donate A Photo
The Janssen Pharmaceutical Companies of Johnson & Johnson recognize World Autoimmune Arthritis Day on May 20, 2018, to raise awareness and support the millions of people around the world living with autoimmune forms of arthritis including rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis (AS) and juvenile idiopathic arthritis (JIA).
To raise awareness and illustrate our commitment to patients living with these conditions, Janssen Immunology is encouraging individuals to participate in a Johnson & Johnson Donate a Photo Campaign to benefit the International Foundation for Autoimmune & Autoinflammatory Arthritis (IFAA) throughout the month of May.
To participate, simply download the Donate a Photo app for iPhone or Android and upload a photo of your choosing once a day, every day in May. For every photo uploaded, Johnson & Johnson will donate $1USD towards raising global awareness of autoimmune and autoinflammatory arthritis to help highlight the important benefits in early detection for patients.*
Please join us in honoring all those who are affected by autoimmune and autoinflammatory forms of arthritis and be sure to share the photos you upload on Facebook, Instagram and Twitter using the hashtags #DonateAPhoto and #WAAD18.
At Janssen Immunology, we are committed to changing the lives of people living with autoimmune and autoinflammatory conditions through scientific research, education and awareness initiatives.
*Johnson & Johnson has curated a list of trusted causes, and you can donate a photo to one cause, once a day. Each cause will appear in the app until it reaches its goal, or the donation period ends. If the goal isn't reached, the cause will still get a minimum donation.
Dan Baker, M.D. joined Janssen Research & Development, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, through Centocor Research & Development in 2000 following an 18-year academic career at the University of Pennsylvania in Philadelphia, Pennsylvania. Since joining Janssen, he has held key roles in the clinical development of the industry-leading Janssen immunology portfolio for a plethora of indications. Dan is a board-certified rheumatologist and as Disease Area Leader for Rheumatoid Arthritis (RA), he is responsible for leading a cross-functional team of experts to outline near- and long-term, prioritized scientific and business strategies with the goal of maintaining industry leadership in RA.
Pearl Pugh, Disease Area Commercial Leader, is responsible for developing and executing the end-to-end strategy for the Rheumatology and Psoriasis Disease Areas. Pearl also provides leadership to global commercial teams to ensure effective partnerships with cross-functional and regional stakeholders for worldwide launch readiness of new products and line extensions, and to maximize current in-market assets worldwide. Prior to joining Janssen Immunology, Pearl was the Director of Marketing, Prostate, at Janssen Oncology US.